Geode Capital Management
SPRB

Geode Capital Management’s Spruce Biosciences SPRB Stock Holding History

Geode Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81M Buy
70,548
+57,659
+447% +$3.22M ﹤0.01% 3027
2026
Q1 		$843K Buy
12,889
+157
+1% +$10.8K ﹤0.01% 3412
2025
Q4 		$1.11M Buy
+12,732
New +$1.36M ﹤0.01% 3343
2025
Q2 		– Sell
-3,689
Closed -$80.3K – 4551
2025
Q1 		$80.3K Buy
3,689
+39
+1% +$1.09K ﹤0.01% 4090
2024
Q4 		$115K Buy
3,650
+157
+4% +$5.75K ﹤0.01% 4063
2024
Q3 		$124K Buy
3,493
+773
+28% +$28.3K ﹤0.01% 4040
2024
Q2 		$106K Buy
2,720
+51
+2% +$2.73K ﹤0.01% 4124
2024
Q1 		$157K Buy
2,669
+437
+20% +$111K ﹤0.01% 4016
2023
Q4 		$491K Hold
2,232
– – ﹤0.01% 3619
2023
Q3 		$378K Sell
2,232
-673
-23% -$113K ﹤0.01% 3710
2023
Q2 		$469K Buy
2,905
+2,097
+260% +$351K ﹤0.01% 3671
2023
Q1 		$134K Hold
808
– – ﹤0.01% 4228
2022
Q4 		$66K Sell
808
-2
-0.2% -$167 ﹤0.01% 4517
2022
Q3 		$83K Hold
810
– – ﹤0.01% 4636
2022
Q2 		$105K Sell
810
-884
-52% -$113K ﹤0.01% 4574
2022
Q1 		$255K Sell
1,694
-206
-11% -$38.3K ﹤0.01% 4259
2021
Q4 		$635K Buy
1,900
+414
+28% +$123K ﹤0.01% 3925
2021
Q3 		$669K Sell
1,486
-228
-13% -$143K ﹤0.01% 3890
2021
Q2 		$1.44M Buy
1,714
+253
+17% +$270K ﹤0.01% 3422
2021
Q1 		$1.82M Sell
1,461
-106
-7% -$163K ﹤0.01% 3293
2020
Q4 		$2.86M Buy
+1,567
New +$2.6M ﹤0.01% 2887

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management's SPRB Position: Q2 2026 in Review

Geode Capital Management increased its Spruce Biosciences (SPRB) stake by 447% in Q2 2026, buying an estimated $3.22M and bringing the position to 70,548 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

Geode Capital Management first reported a position in SPRB in Q4 2020 and has held it in 21 quarters since. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Geode Capital Management held 70,548 shares of Spruce Biosciences worth $3.81M as of Q2 2026.
  • Geode Capital Management bought 57,659 Spruce Biosciences shares in Q2 2026, an estimated $3.22M.
  • Spruce Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3027 holding.
  • Geode Capital Management first reported a position in Spruce Biosciences in Q4 2020 and has held it in 21 quarters since.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.